Dexcom’s new CEO is eyeing growth in the international market as a key strategy for 2026, fresh off the back of the company reporting strong full year 2025 (FY25) revenues. Speaking at the ongoing J.P. Morgan Healthcare Conference, Dexcom’s new CEO Jake Leach said: “We've built our company based on leadership in the US, and we're now going to take that and apply it to the international markets, particularly our ability to open up access and coverage for people with CGM to unlock new opportunities that don ...

Dexcom (NasdaqGS:DXCM) FY Conference January 12, 2026 10:30 AM ET Company ParticipantsNone - Company Representative 2Jake Leach - President and CEONone - Company Representative 1OperatorThanks for joining us at the first session to kick off the 2026 JPMorgan Healthcare Conference. I'll give a warm welcome to the Dexcom CEO, Jake Leach. It's his first time as President and CEO up on stage here. Jake.Jake LeachAll right. Good morning, everybody. Thank you, Robbie. It's an absolute privilege to be able to kick ...